Haifa Shen
Haifa Shen
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
Principles of nanoparticle design for overcoming biological barriers to drug delivery
E Blanco, H Shen, M Ferrari
Nature biotechnology 33 (9), 941-951, 2015
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
X Chen, D Iliopoulos, Q Zhang, Q Tang, MB Greenblatt, M Hatziapostolou, ...
Nature 508 (7494), 103-107, 2014
New genes involved in cancer identified by retroviral tagging
T Suzuki, H Shen, K Akagi, HC Morse, JD Malley, DQ Naiman, ...
Nature genetics 32 (1), 166-174, 2002
Safety of nanoparticles in medicine
J Wolfram, M Zhu, Y Yang, J Shen, E Gentile, D Paolino, M Fresta, G Nie, ...
Current drug targets 16 (14), 1671-1681, 2015
Leukaemia disease genes: large-scale cloning and pathway predictions
J Li, H Shen, KL Himmel, AJ Dupuy, DA Largaespada, T Nakamura, ...
Nature genetics 23 (3), 348-353, 1999
An injectable nanoparticle generator enhances delivery of cancer therapeutics
R Xu, G Zhang, J Mai, X Deng, V Segura-Ibarra, S Wu, J Shen, H Liu, ...
Nature biotechnology 34 (4), 414-418, 2016
The nano-plasma interface: Implications of the protein corona
J Wolfram, Y Yang, J Shen, A Moten, C Chen, H Shen, M Ferrari, Y Zhao
Colloids and Surfaces B: Biointerfaces 124, 17-24, 2014
Nanovector delivery of siRNA for cancer therapy
H Shen, T Sun, M Ferrari
Cancer gene therapy 19 (6), 367-373, 2012
The CDS1 Gene Encoding CDP-diacylglycerol Synthase In Saccharomyces cerevisiae Is Essential for Cell Growth (∗)
H Shen, PN Heacock, CJ Clancey, W Dowhan
Journal of Biological Chemistry 271 (2), 789-795, 1996
Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics
J Shen, HC Kim, H Su, F Wang, J Wolfram, D Kirui, J Mai, C Mu, LN Ji, ...
Theranostics 4 (5), 487, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and response
EJ Koay, MJ Truty, V Cristini, RM Thomas, R Chen, D Chatterjee, Y Kang, ...
The Journal of clinical investigation 124 (4), 2014
E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis
S Ma, XY Tian, Y Zhang, C Mu, H Shen, J Bismuth, HJ Pownall, Y Huang, ...
Scientific reports 6 (1), 1-11, 2016
Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy
G Pasut, D Paolino, C Celia, A Mero, AS Joseph, J Wolfram, D Cosco, ...
Journal of controlled release 199, 106-113, 2015
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
NA Zhao, J Cao, L Xu, Q Tang, LE Dobrolecki, X Lv, M Talukdar, Y Lu, ...
The Journal of clinical investigation 128 (4), 1283-1299, 2018
Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector DeliveryMultistage Vector Delivery of EphA2 siRNA
H Shen, C Rodriguez-Aguayo, R Xu, V Gonzalez-Villasana, J Mai, ...
Clinical Cancer Research 19 (7), 1806-1815, 2013
A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery
J Wolfram, S Nizzero, H Liu, F Li, G Zhang, Z Li, H Shen, E Blanco, ...
Scientific reports 7 (1), 1-13, 2017
High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics
J Shen, R Xu, J Mai, HC Kim, X Guo, G Qin, Y Yang, J Wolfram, C Mu, ...
ACS nano 7 (11), 9867-9880, 2013
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
B Dave, S Granados-Principal, R Zhu, S Benz, S Rabizadeh, ...
Proceedings of the National Academy of Sciences 111 (24), 8838-8843, 2014
Shrinkage of pegylated and non-pegylated liposomes in serum
J Wolfram, K Suri, Y Yang, J Shen, C Celia, M Fresta, Y Zhao, H Shen, ...
Colloids and surfaces B: biointerfaces 114, 294-300, 2014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20